1 completed, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow carbidopa-levodopa 25-100 mg: new trials by email Literature Review of carbidopa-levodopa 25-100 mg trials Research Report on carbidopa-levodopa 25-100 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration carbidopa-levodopa 25-100 mg, placebo for carbidopa-levodopa 25-100 mg - Age-related Macular Degeneration | Phase 2 | Withdrawn | Snyder, Robert W., M.D., Ph.D., P.C. | 2019-09-01 | 2019-04-05 | |
| Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD) carbidopa-levodopa 25-100 mg - Macula; Degeneration, Retina | Phase 2 | Completed | Snyder, Robert W., M.D., Ph.D., P.C. | 35 | 2017-08-01 | 2025-09-12 |
Snyder, Robert W., M.D., Ph.D., P.C. (2)
United States (2)
Robert W Snyder, MD, PhD (2) · Timothy C Fagan, MD (1)